Recursion Pharmaceuticals (RXRX) Sɔɔtɔ Fɔrɛkɛst
Nɔnyɔ nyɛ$3.76Nɔɔ 25 Gbo 2026 21:56 UTC
Nyuɛ-3.09%
AI forecast: RXRX
AI bɔɔ target price fɔ trading day tɛnɛ, week ɛnɛ ɛkpɔ month ɛnɛ ɛkɛ. Change bɔɔ latest price lɛ. Statistical estimates lɛ, not investment advice.
Nɔnyɔ ɔhɛ 6 dɛnɛ a akɛ
Premium shows the AI's price targets for 1 day, 1 week and 1 month for this and every other stock.
Unlock Premium🔒 Nɔ nyɛmɛ nyɛ nyɛmɛ
The forecast track record — every past forecast next to the actual close — is part of Premium.
Unlock PremiumƐŋɛ Nɛ Kɔmpɔni A
Recursion Pharmaceuticals, Inc. operates as a biotechnology company. The company combines artificial intelligence with automation to conduct experimental biology in parallel for testing compounds against cellular disease models. Recursion Pharmaceuticals serves clients worldwide.
